// Primer

7-Hydroxymitragynine, Explained in Plain English

The label reads "7-OH," the forums shorten it to "seven-oh," and the science papers spell out 7-hydroxymitragynine. They all point to the same alkaloid. Here is what it actually is, where it comes from, and what the 2026 rulebook says — no hype, no health claims.

What 7-OH actually is

7-hydroxymitragynine is a single molecule — one specific alkaloid, not a plant, a blend, or a brand. The "7-hydroxy" part of the name describes chemistry: it is the mitragynine molecule with a hydroxyl group (an oxygen-hydrogen pair) attached at the seventh carbon position. That one small change is the entire difference between 7-OH and mitragynine, the compound it is derived from.

In the research literature 7-OH is described as an opioid-receptor-active alkaloid, meaning it binds to the same receptor family that many other plant and pharmaceutical alkaloids interact with. That is a statement about where the molecule docks in laboratory studies, not a claim about what it does for anyone's body — and nothing on this page should be read as one. If you want the pharmacology, read peer-reviewed sources; if you want the plain version, the takeaway is simply that 7-OH is a distinct, well-characterized compound with a known structure.

One naming point trips people up constantly: "7-OH," "7OH," "7-hydroxy," and "seven-oh" are all the same thing. The hyphen and the capitalization drift around between product labels, retailer listings, and message boards, but there is only one compound behind all those spellings. When a listing simply says "7," that is almost always 7-hydroxymitragynine as well — a shorthand that became standard once the category grew large enough to have its own slang.

Where it comes from in the leaf

7-OH occurs naturally in Mitragyna speciosa, the Southeast Asian tree whose leaves are dried and ground into what most people call kratom. But it is a trace alkaloid. In a typical leaf, mitragynine dominates the alkaloid fraction, while 7-hydroxymitragynine usually sits well under 2% of that fraction — often a fraction of a single percent. Reported figures vary by tree, region, harvest, and how the leaf is stored, which is exactly why "it's in the plant" and "you can buy a bottle of it" are two very different statements.

Because the leaf carries so little of it, isolating meaningful quantities of 7-OH directly from kratom would take an impractical amount of raw material. That economic reality is the whole reason the commercial supply looks the way it does.

It is also worth separating 7-OH from the compound people most often confuse it with. Mitragynine is the leaf's headline alkaloid — the one present in bulk and the one traditional kratom powder is effectively sold on. 7-hydroxymitragynine is its close chemical relative, differing by that single hydroxyl group. They are not interchangeable, they are not present in the same proportions, and a product built around one is a fundamentally different thing from a product built around the other. If you keep that distinction straight, most of the marketing language in this category becomes much easier to decode.

How commercial 7-OH is made

The 7-OH in tablets and powders on the market today is, in the overwhelming majority of cases, semi-synthetic. Manufacturers start with mitragynine — the abundant leaf alkaloid — and chemically convert it into 7-hydroxymitragynine through a controlled oxidation step. The starting material is plant-derived; the finished, concentrated alkaloid is the product of a lab process. Calling it "natural" without that context is misleading, and calling it "fully synthetic" is also wrong. Semi-synthetic is the accurate word.

If you want the step-by-step of that conversion written for a general reader, 7ohBlack has a clear walkthrough in how 7-OH is made. The short version: this is chemistry, done deliberately, and the quality of the result depends heavily on how carefully the process is run and how thoroughly the output is tested.

The product formats you'll see

Concentrated 7-OH reaches shelves in a handful of recognizable formats. Knowing them makes product listings far easier to read:

• Tablets. The most common format. Strengths are printed in milligrams — commonly in the 15 mg to 30 mg range per tablet, with some higher-strength lines listing 80 mg or more. Reputable listings state the milligram content per tablet plainly rather than hiding it behind vague "extra strength" language.
• Chewables and dissolvables. A newer category, marketed for convenience and flavor. Same milligram-labeling logic applies.
• Powders. Loose 7-OH powder, sometimes sold by the gram. Powders demand the most scrutiny on testing, because there is no pre-measured unit — the label's stated concentration is the only reference point you have.

Across every format, the number that matters is the stated milligram content and whether an independent lab has verified it. A "30 mg tablet" is only a 30 mg tablet if a certificate of analysis says so. Two products marketed with nearly identical language can carry very different milligram loads, and pricing usually tracks that milligram content more than the size of the bottle — a ten-count of higher-strength tablets can cost more than a fifty-count of a lighter line. Reading the milligram figure first, before the marketing copy, is the single most useful habit when comparing listings.

What 7-OH is not

A few quick corrections clear up most of the confusion around this compound. 7-OH is not whole-leaf kratom, and a bottle of it should not be treated as equivalent to a bag of leaf powder. It is not FDA-approved — no 7-hydroxymitragynine product has been evaluated or cleared by the agency for any use. It is not a dietary supplement in any recognized regulatory sense, regardless of how a listing is styled. And a "trace, naturally occurring" description on the box does not mean the contents were gently extracted from leaves; as covered above, the concentrated material is almost always semi-synthetic. Holding these four facts in mind keeps expectations aligned with reality.

The 2026 regulatory backdrop

As of July 2026, 7-OH is not federally scheduled, but it is squarely in regulators' sights: the U.S. Drug Enforcement Administration has filed a notice of intent to temporarily schedule concentrated 7-hydroxymitragynine, a public comment window on the proposed threshold runs through July 31, 2026, and the earliest date the agency could take formal scheduling action is August 5, 2026. We track that process, deadline by deadline, on our DEA 7-OH timeline.

State rules are a separate patchwork and they move faster than the federal picture. As of mid-2026, 7-OH-containing products are banned or restricted in states including Alabama, Arkansas, Indiana, Rhode Island, Vermont, and Wisconsin. Tennessee and Kansas ended in-state shipping of these products on July 1, 2026. Mississippi treats 7-OH as legal for adults 21 and older, with the exception of eleven northeastern counties that carry local restrictions. Because these lists change often, always confirm your own state's current status before ordering — a product that ships to one address may be blocked at another.

Responsible sourcing

If there is one practical habit worth building around any 7-OH purchase, it is reading the lab work — and insisting it exists. The meaningful standard is per-batch testing at an ISO/IEC 17025-accredited laboratory. ISO 17025 is the international accreditation for testing labs; "per-batch" means the specific lot in your hand was tested, not a flattering result from a batch six months ago.

A certificate of analysis (COA) should confirm the stated milligram content and screen for contaminants. Brands that take this seriously publish those COAs openly rather than emailing a PDF on request — Favor'd Alkz, for example, posts its per-batch ISO 17025 lab results where anyone can match a batch to its paperwork. Whatever brand you consider, the test is the same: can you tie the exact product to an accredited lab's report? If not, treat the milligram number on the label as a marketing figure, not a verified one.

A practical checklist when you are evaluating a source: the batch or lot number on the product matches a published COA; the COA names the accredited lab and shows a recent date; the report lists the measured 7-OH content alongside a contaminant screen; and the seller states plainly where the product does and does not ship. None of that speaks to how a product performs — it speaks to whether the company stands behind what is printed on the label, which is the only thing a buyer can reasonably verify before purchase.

The short version

7-hydroxymitragynine is a single, well-defined alkaloid: a trace component of the kratom leaf that is almost always produced commercially by semi-synthesis from mitragynine, sold as tablets, chewables, or powders labeled by milligram strength, and currently unscheduled at the federal level while a DEA review runs and individual states set their own rules. Understand those few facts — what it is, where it comes from, how it is made, and how it is regulated — and you can read almost any listing in this category with clear eyes.

Common questions